A New Frontier for Patient Safety: The Celiac Safety Act Introduced in Congress

For nearly three million Americans, a routine trip to the grocery store is a high-stakes endeavor, fraught with the constant risk of debilitating illness. While the medical community has long recognized the severe autoimmune nature of celiac disease, federal food labeling laws have lagged significantly behind the clinical reality. That may finally be changing. On May 28, 2026, a bipartisan effort in the U.S. House of Representatives marked a historic milestone for patient advocacy, as Representatives Emanuel Cleaver (D-MO) and Betty McCollum (D-MN) introduced the Celiac Safety Act (H.R.9048).

The proposed legislation aims to modernize the way the United States regulates gluten, bringing the nation into alignment with global standards and providing a vital layer of protection for those who suffer from celiac disease.

---

Main Facts: What the Celiac Safety Act Proposes

The core objective of the Celiac Safety Act is simple yet transformative: to expand the federal definition of "major food allergens" to include all gluten-containing grains. Under current U.S. law, only wheat is officially recognized as a major allergen requiring clear, bolded disclosure on food packaging. This leaves consumers with celiac disease in a precarious position, as other grains that trigger the same severe autoimmune response—specifically barley and rye—are not subject to the same stringent labeling requirements.

If enacted, H.R.9048 would mandate that any product containing barley, rye, or their derivatives be clearly labeled. This would remove the burden of detective work currently placed on patients, who must meticulously scan ingredient lists for obscure terms and hidden sources of gluten. By formalizing these grains as major allergens, the bill would standardize safety protocols across the entire food manufacturing industry.

---

A Chronology of Advocacy: From Consensus to Congress

The journey to H.R.9048 has been a marathon of scientific research and persistent political pressure. The foundation for this legislative push was laid in 2004, during the National Institutes of Health (NIH) Consensus Development Conference on Celiac Disease. It was there that the medical community established the first comprehensive framework for the diagnosis and management of the disease, identifying the necessity for strict gluten avoidance.

Following that conference, the Celiac Disease Foundation (CDF) made the mandatory labeling of all gluten-containing grains a primary pillar of its domestic agenda. For over two decades, the Foundation has worked to bridge the gap between clinical understanding and regulatory action.

The strategy involved a multi-faceted approach:

• 2004–2015: Focus on public awareness and the establishment of diagnostic standards.
• 2016–2024: Intensive lobbying efforts to educate legislators on the distinction between "wheat-free" and "gluten-free."
• 2025: Strategic partnership with Representative Emanuel Cleaver’s office to draft language that met both scientific rigor and legislative feasibility.
• May 2026: The official introduction of H.R.9048, supported by key endorsements from the American Gastroenterological Association and the Society for the Study of Celiac Disease.

---

Supporting Data: Why the Current System Fails

To understand the urgency of the Celiac Safety Act, one must look at the discrepancy between the United States and its international peers. Currently, the U.S. is an outlier among developed nations. Countries including Canada, the United Kingdom, Australia, New Zealand, and all 27 member states of the European Union have long since mandated the labeling of gluten as a major allergen.

In these jurisdictions, the "hidden" nature of barley and rye has been eliminated through regulation. By contrast, American patients are often forced to interpret ambiguous ingredient lists. Ingredients such as "malt flavoring" or "natural flavors"—which frequently contain barley—often appear on U.S. labels without any indication of their gluten content. This lack of transparency is not merely an inconvenience; it is a significant public health failure that leads to preventable, long-term medical complications for celiac patients, including intestinal damage, malabsorption, and an increased risk of associated autoimmune disorders.

Furthermore, the Celiac Disease Foundation has been working on a parallel track at the international level. Just this month, the Foundation helped advance landmark guidelines at the Codex Committee on Food Labelling—a global body that influences international food standards. By establishing a science-based "reference dose" for gluten, the Foundation is ensuring that the United States is not only catching up to global standards but is actively shaping the future of global food safety policy.

---

Official Responses and Stakeholder Perspectives

The introduction of the bill has been met with widespread support from the medical and patient advocacy communities. Marilyn G. Geller, CEO of the Celiac Disease Foundation, articulated the stakes clearly in a recent statement:

"Gluten-containing grains trigger a serious autoimmune response in celiac disease patients, yet current labeling laws fail to recognize that risk with the same clarity afforded to other ingredients listed as major allergens. Recategorizing gluten-containing grains as a major food allergen would strengthen transparency, reduce preventable medical harm, and help millions of Americans make safe food choices with confidence."

The legislative champions behind the bill have emphasized the importance of bipartisanship in protecting vulnerable populations. Representative Betty McCollum, who serves as co-chair of the House Celiac Disease Caucus, has been instrumental in building the political coalition necessary to bring this bill to the floor. Her leadership highlights the growing awareness in Congress that celiac disease is a significant, systemic health issue that requires federal intervention.

Professional medical societies have also stepped forward. The American Gastroenterological Association (AGA) and the Society for the Study of Celiac Disease (SSCD) have both formally endorsed the bill, signaling that the clinical community views this legislation as a vital step in improving patient outcomes.

---

Implications: A New Standard for Food Transparency

The passage of the Celiac Safety Act would represent a tectonic shift in the American food landscape. If the bill becomes law, the following impacts are expected:

1. Enhanced Consumer Confidence

For millions of Americans, grocery shopping would shift from an act of anxiety to one of informed choice. Clear, bolded labels for barley and rye would provide immediate clarity, reducing the incidence of accidental gluten ingestion.

2. Industry Standardization

Food manufacturers would be required to update their labeling processes. While this entails an initial compliance effort, it also simplifies the export process for companies, as their U.S. labels would finally align with the international standards already required in major global markets like the EU and Canada.

3. Reduced Healthcare Costs

Celiac disease is a systemic condition that, when left unmanaged due to accidental exposure, leads to expensive complications. By minimizing accidental gluten intake, the Celiac Safety Act could lead to a long-term reduction in medical costs associated with managing the sequelae of celiac-related intestinal damage.

4. A Template for Future Advocacy

The success of this campaign demonstrates the effectiveness of aligning domestic legislative goals with international scientific standards. It sets a precedent for how patient advocacy groups can work within the legislative process to secure tangible, policy-driven protections for minority health populations.

---

Call to Action: The Path Forward

Despite the momentum, the path to enactment is not guaranteed. The Celiac Safety Act requires sustained pressure on legislators to move through the committee process and eventually to a full vote in the House.

The Celiac Disease Foundation is urging all affected individuals and their allies to take immediate action. The process is designed to be accessible: by contacting local representatives, constituents can voice their support for the bill and demand that it be prioritized. The Foundation has made it simple for citizens to reach out to their representatives through their official website, noting that even a single minute of advocacy can influence the legislative trajectory.

As Congress deliberates on the Celiac Safety Act, the message from the patient community is unified: the time for ambiguity has passed. The health and safety of millions of Americans depend on a food labeling system that accurately reflects the medical realities of the 21st century. By bringing the U.S. in line with the global standard, Congress has the opportunity to make a profound, life-altering impact on the lives of those living with celiac disease.

For those looking to join the movement, the Celiac Disease Foundation continues to serve as the central hub for advocacy, policy expertise, and institutional support. Whether you are a patient, a medical professional, or an organization looking to offer an endorsement, the time to contribute to this historic legislative effort is now.